+$ 0
Billion
+ 0 MIL
Estimated Cancer Survivors by 2024
>$ 0
Billion cost Savings Opportunities
0
Estimated New Cases 2020

Real-World Evidence Generation Solutions

The most expensive drug is the one that doesn't work in real-world settings.

One Step Ahead

Seeking Better Solutions

Recent publication by the National Cancer Institute (NCI), has estimated that total annual costs of cancer care will reach approach ~$250b by 2030 (>20% of the GDP).  The cost of cancer care is increasing exponentially and newly FDA approved targeted therapies costs anywhere from $200,000 to $500,000 per year. More so, there is no real world evidence that outcomes in real world are comparable to outcomes projected in Pivotal FDA registration trials. Outcomes based contracting models based on real world evidence may be one of the only ways to stem the rising costs of cancer treatments in US.  

Cancer Care Innovations is an established 501C3 nonprofit incorporated in the state of Indiana with offices in Indianapolis and Chicago. Cancer Care Innovations is a nonprofit organization created to generate real-world evidence data that many pharmaceutical manufacturers have not yet committed resources to generate and fill a gaps in datasets in the literature that both the FDA and payer organizations are beginning to require for approval and use of prescription pharmaceuticals.

Keeping Cancer Care Costs in Check

Real-World Evidence Models

Outcome based pricing model as a solution for the high cancer care cost. Outcome based pricing can be based on randomized controlled trial data, real world evidence date, scope and breadth of data available to payer.

EMR Databases

Flatiron Databases

Claims Databases

Other

Meet The Team

Yogesh Jethava

MD, FACP

Yogesh Jethava

Yogesh is a practicing Medical Oncologist and co-founder of CCI. Yogesh’s primary responsibilities include

Jan Bassali

PharmD

Jan Bassali

Jan is a seasoned professional of the pharmaceutical industry with experience leading teams in Health Economics and Outcomes Research. Jan received his Doctor of Pharmacy from University of Illinois at Chicago in 2002.

David Kohn

David Kohn

Dave is the former Executive Director of Public Affairs at the Union League Club of Chicago and a member of the Advisory Board of NPR and acting secretary and treasurer of CCI.

The RWE Model

A potential Solution to "The Perfect Storm"

We are facing an unprecidented increase in treatment costs.

01

Data Generation

02

Data Analysis

Real world outcomes are measured.

03

Data Publication

Facing Tomorrow's Challenges

Working together to fuel innovations in cancer care treatment and pricing.

Our Mission

Making a difference

Connecting Real-World Results to Responsible Pharmaceutical Use

Case Studies & Topics

Scroll to Top